Nitric oxide suppresses IL-8 transcription by inhibiting c-Jun N-terminal kinase-induced AP-1 activation

Experimental Cell Research

Volumn 266, Issue 2, 2001, Pages 203-212

  Natarajan, Ramesh ^a   Gupta, Seema ^a   Fisher, Bernard J ^a   Ghosh, Shobha ^a   Fowler III, Alpha A ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Activator protein 1; c Jun N terminal kinase; Interleukin 8; Nitric oxide; Nuclear factor kappa B

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; NITRIC OXIDE; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL LINE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME REPRESSION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; INFLAMMATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

EID: 0034957025     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.2001.5218     Document Type: Article

References (42)

1. Interleukin-8, a chemotactic and inflammatory cytokine
2. Intradermal challenge with interleukin-8 causes tissue oedema and neutrophil accumulation in atopic and non-atopic human subjects
3. Expression of recombinant rabbit IL-8 in E. coli and establishment of the essential involvement of IL-8 in recruiting neutrophils into lipopolysaccharide-induced inflammatory site of rabbit skin
4. Prevention of cerebral edema and infarct in cerebral reperfusion injury by an antibody to interleukin-8
5. Prevention of lung reperfusion injury in rabbits by a monoclonal antibody against interleukin-8
6. Properties of proinflammatory cytokines, interleukin 8 and monocyte chemotactic and activating factor
7. Regulation of human interleukin 8 gene expression and binding of several other members of the intercrine family to receptors for interleukin-8
8. Cooperative interaction of nuclear factor-kappa B- and cis-regulatory enhancer binding protein-like factor binding elements in activating the interleukin-8 gene by pro-inflammatory cytokines
9. Interleukin-8 gene expression in human bronchial epithelial cells
10. Molecular mechanism of interleukin-8 gene expression
11. Regulation of interleukin-8 gene expression
12. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death
13. Activation of SAPK/JNK by TNF receptor 1 through a noncytotoxic TRAF2-dependent pathway
14. Activator protein-1 is the preferred transcription factor for cooperative interaction with nuclear factor-kappaB in respiratory syncytial virus-induced interleukin-8 gene expression in airway epithelium
15. Human T-cell leukemia virus type I Tax transactivates human interleukin 8 gene through acting concurrently on AP-1 and nuclear factor-kappaB-like sites
16. NF-kappaB and AP-1 activation by nitric oxide attenuated apoptotic cell death in RAW 264.7 macrophages
17. Cytokine-mediated transcriptional induction of the human inducible nitric oxide synthase gene requires both activator protein 1 and nuclear factor kappaB-binding sites
18. Nitric oxide decreases cytokine-induced endothelial activation: Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinfiammatory cytokines
19. Nitric oxide regulates interleukin-8 gene expression in activated endothelium by inhibiting NF-kappaB binding to DNA: Effects on endothelial function
20. Nitric oxide: Pathophysiological mechanisms
21. Inhaled nitric oxide for the adult respiratory distress syndrome
22. Pretreatment with inhaled nitric oxide inhibits neutrophil migration and oxidative activity resulting in attenuated sepsis-induced acute lung injury
23. Differential effects of nitric oxide-mediated S-nitro-sylation on p50 and c-jun DNA binding
24. Nitric oxide modulates the c-Jun N-terminal kinase/stress-activated protein kinase activity through activating c-Jun N-terminal kinase kinase
25. Inhibition of AP-1 DNA binding by nitric oxide involving conserved cysteine residues in Jun and Fos
26. Nitric oxide inhibits c-Jun N-terminal kinase 2 (JNK2) via S-nitrosylation
27. Mechanism of action of a dominant-negative mutant of c-Jun
28. Methods for analyzing c-Jun kinase
29. Cross-coupling of the NF-kappa B p65 and Fos/Jun transcription factors produces potentiated biological function
30. The interleukin-8 AP-1 and kappa B-like sites are genetic end targets of FK506-sensitive pathway accompanied by calcium mobilization
31. Tumor necrosis factor alpha and interferon gamma synergistically induce interleukin 8 production in a human gastric cancer cell line through acting concurrently on AP-1 and NF-κB-like binding sites of the interleukin 8 gene
32. AP-1 function and regulation
33. NF-kappa B subunit-specific regulation of the interleukin-8 promoter
34. CCAAT box enhancer binding protein alpha (C/EBP-alpha) stimulates kappaB element-mediated transcription in transfected cells
35. Oct-1 and CCAAT/enhancer-binding protein (C/EBP) bind to overlapping elements within the interleukin-8 promoter: The role of Oct-1 as a transcriptional repressor
36. Inhibition of NF-kappaB DNA binding by nitric oxide
37. Inhibition of endothelial vascular cell adhesion molecule-1 expression by nitric oxide involves the induction and nuclear translocation of IkappaBalpha
38. The regulation of AP-1 activity by mitogen activated protein kinases
39. Transcription factor ATF2 regulation by the JNK signal transduction pathway
40. Heterodimer formation of cJun and ATF-2 is responsible for induction of c-jun by the 243 amino acid adenovirus EIA protein
41. Chemokines and tissue injury
42. Alveolar neutrophil function and cytokine level I patients with adult respiratory distress syndrome during nitric oxide ventilation